BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carlson TJ, Gonzales-Luna AJ, Nebo K, Chan HY, Tran NT, Antony S, Lancaster C, Alam MJ, Begum K, Garey KW. Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection. Open Forum Infect Dis 2020;7:ofaa476. [PMID: 33209956 DOI: 10.1093/ofid/ofaa476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Shahbazi F, Shojaei L, Farvadi F, Kadivarian S. Antimicrobial safety considerations in critically ill patients: part II: focused on anti-microbial toxicities. Expert Rev Clin Pharmacol 2022;:1-11. [PMID: 35734938 DOI: 10.1080/17512433.2022.2093716] [Reference Citation Analysis]
2 Hosseini-Moghaddam SM, Luo B, Bota SE, Husain S, Silverman MS, Daneman N, Brown KA, Paterson JM. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients. JAMA Netw Open 2021;4:e2141089. [PMID: 34964852 DOI: 10.1001/jamanetworkopen.2021.41089] [Reference Citation Analysis]
3 Ressler A, Wang J, Rao K. Defining the black box: a narrative review of factors associated with adverse outcomes from severe Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:17562848211048127. [PMID: 34646358 DOI: 10.1177/17562848211048127] [Reference Citation Analysis]
4 Atamna A, Babich T, Margalit I, Avni T, Ben Zvi H, Raz NE, Yahav D, Bishara J. Does accepted definition of Clostridioides difficile infection (CDI) severity predict poor outcomes in older adults? Aging Clin Exp Res 2022;34:583-9. [PMID: 34426944 DOI: 10.1007/s40520-021-01953-5] [Reference Citation Analysis]
5 Gonzales-Luna AJ, Carlson TJ, Garey KW. Antibiotic Therapies for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc 2021;10:S52-7. [PMID: 34791393 DOI: 10.1093/jpids/piab059] [Reference Citation Analysis]